• mail us help@24marketresearch.com
  • Int'l (+1)-646-781-7170
  • UK(Toll free) +44-800-088-5734

TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Epilepsy Therapeutics Market Size, Status and Forecast 2018-2025

Global Epilepsy Therapeutics Market Size, Status and Forecast 2018-2025

  • Category:Life Sciences
  • Published on : 29 August 2018
  • Pages :90
  • Formats:
  • Report Code:24MRES-3055875
Click for best price

Best Price: $3120

This report focuses on the global Epilepsy Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Epilepsy Therapeutics development in United States, Europe and China.

Epilepsy is a chronic neurological disorder that cause recurrent unprovoked seizures, characterized by brief and undetectable episodes of involuntary movement involving either a body part (partial) or the entire body (generalized).
Neurological disorders treatment market is growing at a significant rate, due to increasing prevalence of neurological disorders and technological advancements in the treatment of these conditions.
United States dominates the global market for epilepsy therapeutics due to increasing prevalence of epilepsy cases in the region.
China and India are expected to be the fastest growing epilepsy therapeutics markets in the Asia. This is due to the large population base and increasing prevalence of epilepsy cases in these countries.
In 2017, the global Epilepsy Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
Abbott Laboratories
Cephalon
Novartis
Pfizer
Johnson & Johnson
GlaxoSmithKline
Sanofi
Sunovion Pharmaceuticals
Valeant Pharmaceuticals
Shire

Market segment by Type, the product can be split into
Anti-epileptic Drugs
Dietary Supplements
Vagal Nerve Stimulation
Surgical Therapies

Market segment by Application, split into
Hospitals
Neurology Centers
Home Care Settings
Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Epilepsy Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Epilepsy Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Epilepsy Therapeutics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENTS

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Epilepsy Therapeutics Market Size Growth Rate by Type (2013-2025)
1.4.2 Anti-epileptic Drugs
1.4.3 Dietary Supplements
1.4.4 Vagal Nerve Stimulation
1.4.5 Surgical Therapies
1.5 Market by Application
1.5.1 Global Epilepsy Therapeutics Market Share by Application (2013-2025)
1.5.2 Hospitals
1.5.3 Neurology Centers
1.5.4 Home Care Settings
1.5.5 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Epilepsy Therapeutics Market Size
2.2 Epilepsy Therapeutics Growth Trends by Regions
2.2.1 Epilepsy Therapeutics Market Size by Regions (2013-2025)
2.2.2 Epilepsy Therapeutics Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Epilepsy Therapeutics Market Size by Manufacturers
3.1.1 Global Epilepsy Therapeutics Revenue by Manufacturers (2013-2018)
3.1.2 Global Epilepsy Therapeutics Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Epilepsy Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Epilepsy Therapeutics Key Players Head office and Area Served
3.3 Key Players Epilepsy Therapeutics Product/Solution/Service
3.4 Date of Enter into Epilepsy Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Epilepsy Therapeutics Market Size by Type (2013-2018)
4.2 Global Epilepsy Therapeutics Market Size by Application (2013-2018)

5 United States
5.1 United States Epilepsy Therapeutics Market Size (2013-2018)
5.2 Epilepsy Therapeutics Key Players in United States
5.3 United States Epilepsy Therapeutics Market Size by Type
5.4 United States Epilepsy Therapeutics Market Size by Application

6 Europe
6.1 Europe Epilepsy Therapeutics Market Size (2013-2018)
6.2 Epilepsy Therapeutics Key Players in Europe
6.3 Europe Epilepsy Therapeutics Market Size by Type
6.4 Europe Epilepsy Therapeutics Market Size by Application

7 China
7.1 China Epilepsy Therapeutics Market Size (2013-2018)
7.2 Epilepsy Therapeutics Key Players in China
7.3 China Epilepsy Therapeutics Market Size by Type
7.4 China Epilepsy Therapeutics Market Size by Application

8 Japan
8.1 Japan Epilepsy Therapeutics Market Size (2013-2018)
8.2 Epilepsy Therapeutics Key Players in Japan
8.3 Japan Epilepsy Therapeutics Market Size by Type
8.4 Japan Epilepsy Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Epilepsy Therapeutics Market Size (2013-2018)
9.2 Epilepsy Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Epilepsy Therapeutics Market Size by Type
9.4 Southeast Asia Epilepsy Therapeutics Market Size by Application

10 India
10.1 India Epilepsy Therapeutics Market Size (2013-2018)
10.2 Epilepsy Therapeutics Key Players in India
10.3 India Epilepsy Therapeutics Market Size by Type
10.4 India Epilepsy Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Epilepsy Therapeutics Market Size (2013-2018)
11.2 Epilepsy Therapeutics Key Players in Central & South America
11.3 Central & South America Epilepsy Therapeutics Market Size by Type
11.4 Central & South America Epilepsy Therapeutics Market Size by Application

12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Epilepsy Therapeutics Introduction
12.1.4 Abbott Laboratories Revenue in Epilepsy Therapeutics Business (2013-2018)
12.1.5 Abbott Laboratories Recent Development
12.2 Cephalon
12.2.1 Cephalon Company Details
12.2.2 Company Description and Business Overview
12.2.3 Epilepsy Therapeutics Introduction
12.2.4 Cephalon Revenue in Epilepsy Therapeutics Business (2013-2018)
12.2.5 Cephalon Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Epilepsy Therapeutics Introduction
12.3.4 Novartis Revenue in Epilepsy Therapeutics Business (2013-2018)
12.3.5 Novartis Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Epilepsy Therapeutics Introduction
12.4.4 Pfizer Revenue in Epilepsy Therapeutics Business (2013-2018)
12.4.5 Pfizer Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Epilepsy Therapeutics Introduction
12.5.4 Johnson & Johnson Revenue in Epilepsy Therapeutics Business (2013-2018)
12.5.5 Johnson & Johnson Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Details
12.6.2 Company Description and Business Overview
12.6.3 Epilepsy Therapeutics Introduction
12.6.4 GlaxoSmithKline Revenue in Epilepsy Therapeutics Business (2013-2018)
12.6.5 GlaxoSmithKline Recent Development
12.7 Sanofi
12.7.1 Sanofi Company Details
12.7.2 Company Description and Business Overview
12.7.3 Epilepsy Therapeutics Introduction
12.7.4 Sanofi Revenue in Epilepsy Therapeutics Business (2013-2018)
12.7.5 Sanofi Recent Development
12.8 Sunovion Pharmaceuticals
12.8.1 Sunovion Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Epilepsy Therapeutics Introduction
12.8.4 Sunovion Pharmaceuticals Revenue in Epilepsy Therapeutics Business (2013-2018)
12.8.5 Sunovion Pharmaceuticals Recent Development
12.9 Valeant Pharmaceuticals
12.9.1 Valeant Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Epilepsy Therapeutics Introduction
12.9.4 Valeant Pharmaceuticals Revenue in Epilepsy Therapeutics Business (2013-2018)
12.9.5 Valeant Pharmaceuticals Recent Development
12.10 Shire
12.10.1 Shire Company Details
12.10.2 Company Description and Business Overview
12.10.3 Epilepsy Therapeutics Introduction
12.10.4 Shire Revenue in Epilepsy Therapeutics Business (2013-2018)
12.10.5 Shire Recent Development

13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

LIST OF TABLES & FIGURES

List of Tables and Figures

Table Epilepsy Therapeutics Key Market Segments
Table Key Players Epilepsy Therapeutics Covered
Table Global Epilepsy Therapeutics Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Epilepsy Therapeutics Market Size Market Share by Type 2013-2025
Figure Anti-epileptic Drugs Figures
Table Key Players of Anti-epileptic Drugs
Figure Dietary Supplements Figures
Table Key Players of Dietary Supplements
Figure Vagal Nerve Stimulation Figures
Table Key Players of Vagal Nerve Stimulation
Figure Surgical Therapies Figures
Table Key Players of Surgical Therapies
Table Global Epilepsy Therapeutics Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospitals Case Studies
Figure Neurology Centers Case Studies
Figure Home Care Settings Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Epilepsy Therapeutics Report Years Considered
Table Global Epilepsy Therapeutics Market Size 2013-2025 (Million US$)
Figure Global Epilepsy Therapeutics Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Epilepsy Therapeutics Market Size by Regions 2013-2025 (Million US$)
Table Global Epilepsy Therapeutics Market Size by Regions 2013-2018 (Million US$)
Table Global Epilepsy Therapeutics Market Share by Regions 2013-2018
Figure Global Epilepsy Therapeutics Market Share by Regions 2013-2018
Figure Global Epilepsy Therapeutics Market Share by Regions 2018
Table Market Top Trends
Table Global Epilepsy Therapeutics Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Epilepsy Therapeutics Market Share by Manufacturers (2013-2018)
Figure Global Epilepsy Therapeutics Market Share by Manufacturers in 2018
Table Global Epilepsy Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Epilepsy Therapeutics Product/Solution/Service
Table Date of Enter into Epilepsy Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Epilepsy Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Global Epilepsy Therapeutics Market Size Share by Type (2013-2018)
Figure Global Epilepsy Therapeutics Market Size Market Share by Type (2013-2018)
Table Global Epilepsy Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Global Epilepsy Therapeutics Market Size Share by Application (2013-2018)
Figure Global Epilepsy Therapeutics Market Size Market Share by Application (2013-2018)
Figure Global Epilepsy Therapeutics Revenue Market Share by Application in 2017
Figure United States Epilepsy Therapeutics Market Size 2013-2018 (Million US$)
Table United States Key Players Epilepsy Therapeutics Revenue (2017-2018) (Million US$)
Table United States Key Players Epilepsy Therapeutics Market Share (2017-2018)
Table United States Epilepsy Therapeutics Market Size by Type (2013-2018) (Million US$)
Table United States Epilepsy Therapeutics Market Share by Type (2013-2018)
Table United States Epilepsy Therapeutics Market Size by Application (2013-2018) (Million US$)
Table United States Epilepsy Therapeutics Market Share by Application (2013-2018)
Figure Europe Epilepsy Therapeutics Market Size 2013-2018 (Million US$)
Table Europe Key Players Epilepsy Therapeutics Revenue (2017-2018) (Million US$)
Table Europe Key Players Epilepsy Therapeutics Market Share (2017-2018)
Table Europe Epilepsy Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Europe Epilepsy Therapeutics Market Share by Type (2013-2018)
Table Europe Epilepsy Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Europe Epilepsy Therapeutics Market Share by Application (2013-2018)
Figure China Epilepsy Therapeutics Market Size 2013-2018 (Million US$)
Table China Key Players Epilepsy Therapeutics Revenue (2017-2018) (Million US$)
Table China Key Players Epilepsy Therapeutics Market Share (2017-2018)
Table China Epilepsy Therapeutics Market Size by Type (2013-2018) (Million US$)
Table China Epilepsy Therapeutics Market Share by Type (2013-2018)
Table China Epilepsy Therapeutics Market Size by Application (2013-2018) (Million US$)
Table China Epilepsy Therapeutics Market Share by Application (2013-2018)
Figure Japan Epilepsy Therapeutics Market Size 2013-2018 (Million US$)
Table Japan Key Players Epilepsy Therapeutics Revenue (2017-2018) (Million US$)
Table Japan Key Players Epilepsy Therapeutics Market Share (2017-2018)
Table Japan Epilepsy Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Japan Epilepsy Therapeutics Market Share by Type (2013-2018)
Table Japan Epilepsy Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Japan Epilepsy Therapeutics Market Share by Application (2013-2018)
Figure Southeast Asia Epilepsy Therapeutics Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Epilepsy Therapeutics Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Epilepsy Therapeutics Market Share (2017-2018)
Table Southeast Asia Epilepsy Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Epilepsy Therapeutics Market Share by Type (2013-2018)
Table Southeast Asia Epilepsy Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Epilepsy Therapeutics Market Share by Application (2013-2018)
Figure India Epilepsy Therapeutics Market Size 2013-2018 (Million US$)
Table India Key Players Epilepsy Therapeutics Revenue (2017-2018) (Million US$)
Table India Key Players Epilepsy Therapeutics Market Share (2017-2018)
Table India Epilepsy Therapeutics Market Size by Type (2013-2018) (Million US$)
Table India Epilepsy Therapeutics Market Share by Type (2013-2018)
Table India Epilepsy Therapeutics Market Size by Application (2013-2018) (Million US$)
Table India Epilepsy Therapeutics Market Share by Application (2013-2018)
Figure Central & South America Epilepsy Therapeutics Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Epilepsy Therapeutics Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Epilepsy Therapeutics Market Share (2017-2018)
Table Central & South America Epilepsy Therapeutics Market Size by Type (2013-2018) (Million US$)
Table Central & South America Epilepsy Therapeutics Market Share by Type (2013-2018)
Table Central & South America Epilepsy Therapeutics Market Size by Application (2013-2018) (Million US$)
Table Central & South America Epilepsy Therapeutics Market Share by Application (2013-2018)
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Epilepsy Therapeutics Business (2013-2018) (Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Epilepsy Therapeutics Business (2013-2018)
Table Abbott Laboratories Recent Development
Table Cephalon Company Details
Table Cephalon Revenue in Epilepsy Therapeutics Business (2013-2018)(Million US$)
Figure Cephalon Revenue Growth Rate in Epilepsy Therapeutics Business (2013-2018)
Table Cephalon Recent Development
Table Novartis Company Details
Table Novartis Revenue in Epilepsy Therapeutics Business (2013-2018)(Million US$)
Figure Novartis Revenue Growth Rate in Epilepsy Therapeutics Business (2013-2018)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Epilepsy Therapeutics Business (2013-2018)(Million US$)
Figure Pfizer Revenue Growth Rate in Epilepsy Therapeutics Business (2013-2018)
Table Pfizer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Epilepsy Therapeutics Business (2013-2018)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Epilepsy Therapeutics Business (2013-2018)
Table Johnson & Johnson Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Epilepsy Therapeutics Business (2013-2018)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Epilepsy Therapeutics Business (2013-2018)
Table GlaxoSmithKline Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Epilepsy Therapeutics Business (2013-2018)(Million US$)
Figure Sanofi Revenue Growth Rate in Epilepsy Therapeutics Business (2013-2018)
Table Sanofi Recent Development
Table Sunovion Pharmaceuticals Company Details
Table Sunovion Pharmaceuticals Revenue in Epilepsy Therapeutics Business (2013-2018)(Million US$)
Figure Sunovion Pharmaceuticals Revenue Growth Rate in Epilepsy Therapeutics Business (2013-2018)
Table Sunovion Pharmaceuticals Recent Development
Table Valeant Pharmaceuticals Company Details
Table Valeant Pharmaceuticals Revenue in Epilepsy Therapeutics Business (2013-2018)(Million US$)
Figure Valeant Pharmaceuticals Revenue Growth Rate in Epilepsy Therapeutics Business (2013-2018)
Table Valeant Pharmaceuticals Recent Development
Table Shire Company Details
Table Shire Revenue in Epilepsy Therapeutics Business (2013-2018)(Million US$)
Figure Shire Revenue Growth Rate in Epilepsy Therapeutics Business (2013-2018)
Table Shire Recent Development
Table Global Epilepsy Therapeutics Market Size by Regions (Million US$) 2018-2025
Figure Global Epilepsy Therapeutics Market Size Share by Regions (2018-2025)
Figure Global Epilepsy Therapeutics Market Size Share by Regions in 2025
Figure United States Epilepsy Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Europe Epilepsy Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure China Epilepsy Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Japan Epilepsy Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Epilepsy Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure India Epilepsy Therapeutics Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Epilepsy Therapeutics Market Size Forecast (2018-2025)(Million USD)
Table Global Epilepsy Therapeutics Market Size by Product (2018-2025) (Million US$)
Figure Global Epilepsy Therapeutics Market Size by Product (2018-2025)
Figure Global Epilepsy Therapeutics Market Size by Product in 2025
Table Global Epilepsy Therapeutics Market Size by Application (2018-2025) (Million US$)
Figure Global Epilepsy Therapeutics Market Size by Application (2018-2025)
Figure Global Epilepsy Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

SELECT A FORMAT

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy
check discount